Transdermal N-[N-[5-[4-(aminoiminomethly)phenyl]-1-oxopentyl]-L- -aspartyl]-L-phenylalainine or its esters and their pharmaceutically acceptable salts

Transdermal N-[N-[5-[4-(aminoiminomethly)phenyl]-1-oxopentyl]-L- -aspartyl]-L-phenylalainine or its esters and their pharmaceutically acceptable salts

The present invention is for pharmaceutical compositions for transdermal delivery of N-[N-[5-[4-(aminoiminomethyl)phenyl-1-oxopentyl]-L- -aspartyl]-L-phenylalanine or its esters and their pharmaceutically acceptable salts which are useful as platelet aggregation inhibitors. The present invention is...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Feigen, Larry P, Griffin, Martin John
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Feigen, Larry P
Griffin, Martin John
description The present invention is for pharmaceutical compositions for transdermal delivery of N-[N-[5-[4-(aminoiminomethyl)phenyl-1-oxopentyl]-L- -aspartyl]-L-phenylalanine or its esters and their pharmaceutically acceptable salts which are useful as platelet aggregation inhibitors. The present invention is for pharmaceutical compositions and a method of use for the transdermal delivery of N-[N-[5-[4-(aminoiminomethyl)phenyl]-1-oxopentyl]-L- -aspartyl]-L-phenylalanine or its esters and their pharmaceutically acceptable salts which are useful as platelet aggregation inhibitors.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_06387880</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>06387880</sourcerecordid><originalsourceid>FETCH-uspatents_grants_063878803</originalsourceid><addsrcrecordid>eNqNjr0KwkAQhNNYiPoOW2pxEIk_6UWxEKt0QWSNqznYXI7bFcyL-LxeMA8gDDMMDHwzTj5FQCd3Cg0ynE0ZtTblysyxsa61vTWkNXcLX5Pr-GKWpn23npz25WTAoHgMQ_uNkNE66wjaAFYFSJSCALo7aE02gK8xAit6qa2QuQOsKvKKNyYQZJVpMnogC82GnCRw2Be7o3lFmEa4XJ_xeIx0k-XbPE-zPyZfcrJR3Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Transdermal N-[N-[5-[4-(aminoiminomethly)phenyl]-1-oxopentyl]-L- -aspartyl]-L-phenylalainine or its esters and their pharmaceutically acceptable salts</title><source>USPTO Issued Patents</source><creator>Feigen, Larry P ; Griffin, Martin John</creator><creatorcontrib>Feigen, Larry P ; Griffin, Martin John ; G.D. Searle &amp; Co</creatorcontrib><description>The present invention is for pharmaceutical compositions for transdermal delivery of N-[N-[5-[4-(aminoiminomethyl)phenyl-1-oxopentyl]-L- -aspartyl]-L-phenylalanine or its esters and their pharmaceutically acceptable salts which are useful as platelet aggregation inhibitors. The present invention is for pharmaceutical compositions and a method of use for the transdermal delivery of N-[N-[5-[4-(aminoiminomethyl)phenyl]-1-oxopentyl]-L- -aspartyl]-L-phenylalanine or its esters and their pharmaceutically acceptable salts which are useful as platelet aggregation inhibitors.</description><language>eng</language><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6387880$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,778,800,883,64024</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6387880$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Feigen, Larry P</creatorcontrib><creatorcontrib>Griffin, Martin John</creatorcontrib><creatorcontrib>G.D. Searle &amp; Co</creatorcontrib><title>Transdermal N-[N-[5-[4-(aminoiminomethly)phenyl]-1-oxopentyl]-L- -aspartyl]-L-phenylalainine or its esters and their pharmaceutically acceptable salts</title><description>The present invention is for pharmaceutical compositions for transdermal delivery of N-[N-[5-[4-(aminoiminomethyl)phenyl-1-oxopentyl]-L- -aspartyl]-L-phenylalanine or its esters and their pharmaceutically acceptable salts which are useful as platelet aggregation inhibitors. The present invention is for pharmaceutical compositions and a method of use for the transdermal delivery of N-[N-[5-[4-(aminoiminomethyl)phenyl]-1-oxopentyl]-L- -aspartyl]-L-phenylalanine or its esters and their pharmaceutically acceptable salts which are useful as platelet aggregation inhibitors.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNjr0KwkAQhNNYiPoOW2pxEIk_6UWxEKt0QWSNqznYXI7bFcyL-LxeMA8gDDMMDHwzTj5FQCd3Cg0ynE0ZtTblysyxsa61vTWkNXcLX5Pr-GKWpn23npz25WTAoHgMQ_uNkNE66wjaAFYFSJSCALo7aE02gK8xAit6qa2QuQOsKvKKNyYQZJVpMnogC82GnCRw2Be7o3lFmEa4XJ_xeIx0k-XbPE-zPyZfcrJR3Q</recordid><startdate>20020514</startdate><enddate>20020514</enddate><creator>Feigen, Larry P</creator><creator>Griffin, Martin John</creator><scope>EFH</scope></search><sort><creationdate>20020514</creationdate><title>Transdermal N-[N-[5-[4-(aminoiminomethly)phenyl]-1-oxopentyl]-L- -aspartyl]-L-phenylalainine or its esters and their pharmaceutically acceptable salts</title><author>Feigen, Larry P ; Griffin, Martin John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_063878803</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2002</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Feigen, Larry P</creatorcontrib><creatorcontrib>Griffin, Martin John</creatorcontrib><creatorcontrib>G.D. Searle &amp; Co</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Feigen, Larry P</au><au>Griffin, Martin John</au><aucorp>G.D. Searle &amp; Co</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Transdermal N-[N-[5-[4-(aminoiminomethly)phenyl]-1-oxopentyl]-L- -aspartyl]-L-phenylalainine or its esters and their pharmaceutically acceptable salts</title><date>2002-05-14</date><risdate>2002</risdate><abstract>The present invention is for pharmaceutical compositions for transdermal delivery of N-[N-[5-[4-(aminoiminomethyl)phenyl-1-oxopentyl]-L- -aspartyl]-L-phenylalanine or its esters and their pharmaceutically acceptable salts which are useful as platelet aggregation inhibitors. The present invention is for pharmaceutical compositions and a method of use for the transdermal delivery of N-[N-[5-[4-(aminoiminomethyl)phenyl]-1-oxopentyl]-L- -aspartyl]-L-phenylalanine or its esters and their pharmaceutically acceptable salts which are useful as platelet aggregation inhibitors.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_06387880
source USPTO Issued Patents
title Transdermal N-[N-[5-[4-(aminoiminomethly)phenyl]-1-oxopentyl]-L- -aspartyl]-L-phenylalainine or its esters and their pharmaceutically acceptable salts
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T11%3A56%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Feigen,%20Larry%20P&rft.aucorp=G.D.%20Searle%20&%20Co&rft.date=2002-05-14&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E06387880%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true